Announcements Trials
Browse Landscape

Phase

Phase 2 127Phase 1 38Phase 1/2 27Phase NA 16Phase 3 15Phase 2/3 3Phase EARLY_PHASE1 2Phase 4 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 3Lymphoid 2Other hematologic neoplasm 1

Conditions

Lymphoma, T-Cell 1Lymphoma, B-Cell 1Leukemia, T-Cell 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 21fludarabine 12Rituximab 10Vincristine 6Etoposide 6Prednisone 5Doxorubicin 5pembrolizumab 4Radiotherapy 4Methotrexate 4Magnetic Resonance Spectroscopy 4Immunotherapy, Adoptive 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Dexamethasone 4venetoclax 3ibrutinib 3Nivolumab 3Imiquimod 3Ifosfamide 3Exercise 3Biopsy 368Ga-pentixafor 3fludarabine phosphate 2daratumumab 2Transplantation 2Stem Cell Transplantation 2Specimen Handling 2Sirolimus 2Roflumilast 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Melphalan × Lymphoid × Clear all
NCT04264078 2021-06-28

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Xinqiao Hospital of Chongqing

Phase EARLY_PHASE1 Unknown
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

NCT04264039 2020-02-11

Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies

Xinqiao Hospital of Chongqing

Phase EARLY_PHASE1 Unknown
30 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡